Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary TuberculosisWilliam J. Burman, Richard E. Chaisson, Stefan Goldberg et al.|American Journal of Respiratory and Critical Care Medicine|2006Cited by 285
Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and TuberculosisMarc Weiner, Thomas Hodge, Debra Benator et al.|Clinical Infectious Diseases|2005Cited by 227
Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19Takato Kusakabe, Iliyan D. Iliev, Marissa Mesko et al.|Nature Immunology|2023Cited by 77